HOME > BUSINESS
BUSINESS
- Teva Takeda Discloses Info on Producing Countries of Its Generic APIs
March 7, 2019
- Sawai’s Generic Abilify Approved for Depression
March 7, 2019
- Xofluza Filed in US to Treat Patients at High Risk of Flu-Related Complications: Shionogi
March 7, 2019
- Japan’s 1st Drug to Reduce Alcohol Consumption Launched: Otsuka
March 6, 2019
- Alcon Pharma to Be Integrated into Novartis Japan in April
March 6, 2019
- Bayer Submits Prostate Cancer Drug Darolutamide in Japan
March 6, 2019
- Pfizer Japan Logs 2.6% Growth in FY2018, No Job Cut Planned: Chief
March 6, 2019
- Sawai Recalls GI Drug after Doping Substance Found
March 6, 2019
- Fujifilm, Tokyo Medical and Dental Univ. Ink Regenerative Medicine Pact for Meniscal Injury
March 6, 2019
- Osteoporosis Drug Evenity Now Available: Amgen Astellas
March 5, 2019
- ASKA to Relocate Kawasaki Research Center to Shonan iPark; 1st Non-Takeda Pharma Tenant
March 5, 2019
- Teijin Pharma’s Feburic Now Available in China
March 5, 2019
- Sumitomo Dainippon to Bolster Functions in Singapore Subsidiary; Maximizing South East Asian Biz
March 5, 2019
- Pfizer Japan Rolls Out EGFR Inhibitor Vizimpro
March 4, 2019
- Kyowa Kirin Resubmits Istradefylline for US Approval for 1st time in 12 Years, Based on Japanese Data
March 4, 2019
- Nichi-Iko Scoops Up FDA-Approved Manufacturing Plant in US from Danish Pharma
March 4, 2019
- Shionogi Strikes Malaria Pact with Nagasaki University
March 1, 2019
- Kaken Grabs Japan Rights to Arbor’s Head Lice Drug
March 1, 2019
- Taisho to Snap Up More Shares in Vietnam’s DHG, Boost Southeast Asian Biz
March 1, 2019
- More Pharmacies Turning to Medical System Network’s Price Negotiation Service after Distribution Guidelines Introduced
March 1, 2019
ページ
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
